Xeris Biopharma Holdings Inc
NASDAQ:XERS

Watchlist Manager
Xeris Biopharma Holdings Inc Logo
Xeris Biopharma Holdings Inc
NASDAQ:XERS
Watchlist
Price: 4.02 USD -2.19% Market Closed
Market Cap: 618.8m USD
Section:
Dividends
Dividends
Shareholder Yield
Buybacks
Debt Paydown
Price Appreciation
Stock Splits
See Also

Dividends

Xeris Biopharma Holdings Inc
does not pay dividends

Shareholder Yield

Current shareholder yield for XERS is -16.21%.

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
-16.21%
= Dividend Yield
0%
+ Buyback Yield
-8.18%
+ Debt Paydown Yield
-8.03%
-16.21%
Shareholder Yield
Dividend Yield
No dividends
-8.18%
Buyback Yield
Lowest
-119.12%
Average
-46.01%
Highest
-1.33%
-8.03%
Debt Paydown Yield
Lowest
-39.38%
Average
-14.22%
Highest
18.3%

Peers Comparison
Shareholder Yield

Company Total Yield Dividend Yield Buyback Yield Debt Paydown Yield

Buybacks

Buyback Yield
Xeris Biopharma Holdings Inc

Period
3Y
5Y
10Y
15Y
30Y
Yield Statistics, Past 5 Years
Min
Max
Current Yield
Min Yield
Max Yield
Average Yield
Median Yield

Peers Comparison
Buybacks

Company Buyback Yield Average Yield (3Y) Average Yield (5Y) Average Yield (10Y)

Debt Paydown

Debt Paydown Yield
Xeris Biopharma Holdings Inc

Period
3Y
5Y
10Y
15Y
30Y
Yield Statistics, Past 5 Years
Min
Max
Current Yield
Min Yield
Max Yield
Average Yield
Median Yield

Peers Comparison
Debt Paydown

Company Debt Paydown Yield Average Yield (3Y) Average Yield (5Y) Average Yield (10Y)

Price Appreciation

XERS Price
Xeris Biopharma Holdings Inc

1M 1M
-32%
6M 6M
+33%
1Y 1Y
+126%
3Y 3Y
+73%
5Y 5Y
+141%
10Y 10Y
-80%
Annual Price Range
4.02
52w Low
1.7
52w High
5.87
Price Metrics
Average Annual Return 53.24%
Standard Deviation of Annual Returns 132.23%
Max Drawdown -86%
Shares Statistics
Market Capitalization 600.7m USD
Shares Outstanding 153 940 000
Percentage of Shares Shorted 11.33%

XERS Return Decomposition
Main factors of price return

What is price return decomposition?

Stock Splits

XERS's latest stock split occurred on Oct 6, 2021

The company executed a 1-for-1 stock split, meaning that for every share held, investors received 1 new share.

Before the split, XERS traded at 2.37 per share. Afterward, the share price was about 2.36.

The adjusted shares began trading on Oct 6, 2021. This was the only stock split in XERS's history.

View XERS Stock Splits
Pre-Split Price
2.37 2.37
Post-Split Price
2.36
Before
After
View Stock Splits

See Also

Summary
XERS intrinsic value, competitors valuation, and company profile.
DCF Valuation
XERS stock valuation using Discount Cash Flow valuation method.
Relative Valuation
XERS stock valuation using valuation multiples.
Wall Street Estimates
XERS price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
XERS stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 248,100+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.